Systematic reviews identify 36 studies demonstrating that BPC-157 improves functional, structural, and biomechanical outcomes across muscle, tendon, ligament, and bone injuries in preclinical models, with the peptide enhancing collagen synthesis, improving tensile strength, and accelerating cellular proliferation in tendon fibroblasts through FAK-paxillin pathway activation critical for cellular adhesion, migration, proliferation, and survival
Dihexa has zero human clinical data no trials, no pharmacokinetic studies, and no safety assessments in humans have been conducted
Tempistiche: prima di iniziare, a 4 settimane, a 8 settimane, poi trimestrale in uso prolungato
As we age, peptide levels may decline